Table 3.
Recurrence Pattern Analysis Using Competing Risk Methodology. A. Hematogenous Recurrences; B. Peritoneal Recurrences
| A. Hematogenous Recurrences | |||||
|---|---|---|---|---|---|
| Variable | Pt# | Hematogenous Recurrences | Death# | CIF at 3Yr (95%CI) | p-value |
| Total Cohort | 140 | 61 | 2 | 40.8% (32.2-49.5%) | |
| Specimen Manipulation | |||||
| Non-morcellated | 98 | 50 | 2 | 49.4% (38.6-60.1%) | 0.002 |
| Morcellation | 42 | 11 | 0 | 21.9% (8.9-34.9%) | |
| B. Peritoneal Recurrences | |||||
| Variable | Pt# | Peritoneal Recurrences | Death# | CIF at 3Yr (95%CI) | p-value |
| Total Cohort | 140 | 37 | 2 | 27.8% (20-35.7%) | |
| Specimen Manipulation | |||||
| Non-morcellated | 98 | 13 | 2 | 15% (7.4-22.6%) | <0.001 |
| Morcellation | 42 | 24 | 0 | 56.3% (40.7-72%) | |
Note: p-values that appear in red are significant.
CIF, Cumulative incidence of failure